Formed in 2009, the Archive Team (not to be confused with the archive.org Archive-It Team) is a rogue archivist collective dedicated to saving copies of rapidly dying or deleted websites for the sake of history and digital heritage. The group is 100% composed of volunteers and interested parties, and has expanded into a large amount of related projects for saving online and digital history.
Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Health Highlights: Jan. 25, 2021
Severe Allergic Reactions to Moderna COVID-19 Vaccine Rare: CDC Only 10 people in the entire United States have had severe allergic reactions to Moderna's...
2.5 Anaphylaxis Cases Reported Per Million COVID-19 Moderna Vaccine Shots
MONDAY, Jan. 25, 2021 -- The rate of anaphylaxis is 2.5 cases per million Moderna COVID-19 vaccine doses administered as of Jan. 10, 2021, according to...
Daily Aspirin Can Lower Colon Cancer Risk, But Age Matters
MONDAY, Jan. 25, 2021 -- Low-dose aspirin may help some people curb their risk of developing colon cancer -- but not if they wait until age 70 to start, a...
Fried Food Intake May Increase Cardiovascular Disease Risk
MONDAY, Jan. 25, 2021 -- Fried food consumption is associated with an increased risk for cardiovascular disease, according to a meta-analysis published online...
AHA News: Hospice Candidate at 2, She's Now 13 and Thriving
MONDAY, Jan. 25, 2021 (American Heart Association News) -- Rosemary "Rosie" Veltz was "medically maxed out." That was the term the doctors used six months...
Vitamin D Deficiency Associated With Increased COVID-19 Risk
MONDAY, Jan. 25, 2021 -- Patients with vitamin D deficiency are significantly more likely to be positive for COVID-19, according to a study published in the...
Strong Blood Thinners May Help COVID-19 Patients, But Degree of Illness Is Key
MONDAY, Jan. 25, 2021 -- Full doses of blood thinners can benefit patients hospitalized with COVID-19, but the severity of their illness matters, researchers...
Full-Dose Heparin May Aid Moderately Ill COVID-19 Patients
MONDAY, Jan. 25, 2021 -- Evidence suggests that full-dose anticoagulation treatment reduces the need for vital organ support such as ventilation and may reduce...
Revised WIC Food Package May Aid Child Development
MONDAY, Jan. 25, 2021 -- Revisions to the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) may offer downstream child health...
Therapeutic Vaccine Is Keeping Melanoma in Remission 4 Years On
MONDAY, Jan. 25, 2021 -- Giving melanoma patients a "personalized" vaccine can prompt an anti-tumor immune response that lasts for years, an early study...
FDA Approves Lupkynis (voclosporin) for Adult Patients with Active Lupus Nephritis
VICTORIA, British Columbia & ROCKVILLE, Md.-- January 22, 2021 -- Aurinia Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration...
U.S. Food and Drug Administration Approves Opdivo (nivolumab) in Combination with Cabometyx (cabozantinib) as First-line Treatment for Patients with Advanced Renal Cell Carcinoma
PRINCETON, N.J.--(BUSINESS WIRE) January 22, 2021-- Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 240 mg (injection for intravenous...
FDA Approves Cabenuva (cabotegravir and rilpivirine) Long-Acting Injectable HIV Treatment and Vocabria (cabotegravir) Oral HIV Treatment
London, 21 January 2021 – ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc....
FDA Approves Verquvo (vericiguat) for Heart Failure with Reduced Ejection Fraction
KENILWORTH, N.J.--(BUSINESS WIRE) January 20, 2021-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food...
Darzalex Faspro (daratumumab and hyaluronidase-fihj) Becomes the First FDA-Approved Treatment for Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
January 15, 2021 (HORSHAM, Pa.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration...
Marius Pharmaceuticals Submits New Drug Application to U.S. FDA for Kyzatrex Next-generation Oral Testosterone Replacement Therapy in Male Patients with Hypogonadism
Raleigh, N.C., Jan. 5, 2021 — Marius Pharmaceuticals, a specialty pharmaceutical company focusing on treating conditions that are primarily associated...
US FDA Accepts Regulatory Submission from Pfizer and OPKO for Review of Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency
NEW YORK & MIAMI--(BUSINESS WIRE) Monday, January 04, 2021 -- Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the US Food...
FDA Accepts Alkermes' Resubmission of New Drug Application for ALKS 3831
DUBLIN, Dec. 29, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of...
Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombi
NEW YORK--(BUSINESS WIRE)--Dec. 29, 2020-- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company with Phase 3 programs in...
Cara Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for Korsuva Injection in Hemodialysis Patients with Moderate-to-Severe Pruritus
STAMFORD, Conn., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and...
Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture
New York and Mainz, Germany, January 20, 2021 — Today, Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced results from an in vitro study...
FDA Grants Fast Track Designation to Padeliporfin ImPACT for Steba Biotech
LUXEMBOURG, Jan. 17, 2021 /PRNewswire/ -- Steba biotech, pioneering developer of the IMmune Photo Activate Cancer Treatment (ImPACT), announced today that the...
GSK Presents Positive Efficacy Data of Dostarlimab in Mismatch Repair-Deficient (dMMR) Solid Cancers at ASCO Gastrointestinal Cancers Symposium
London, UK -- 16 January 2021 GlaxoSmithKline (GSK) plc announced updated data from GARNET cohort F evaluating dostarlimab in mismatch repair-deficient (dMMR)...
Lexicon Pharmaceuticals Provides Regulatory Update on Sotagliflozin in Heart Failure
The Woodlands, Texas, January 14, 2021 – Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that it has received U.S. Food and Drug...
Novartis Ligelizumab (QGE031) Receives FDA Breakthrough Therapy Designation for Patients with Chronic Idiopathic Urticaria (CIU)
East Hanover, January 14, 2021 — Novartis today announced that the US Food and Drug Administration (FDA) has granted ligelizumab (QGE031) Breakthrough...
Browse by News Type
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
- Drug Shortages
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
